Inactive Instrument
Argos Therapeutics Inc Stock Nasdaq
Stocks
US0402211033
Pharmaceuticals
OTC Markets Traded| Market Cap | 318K 284K 262K 237K 444K 30.15M 452K 3.15M 1.25M 15.8M 1.19M 1.17M 49.8M | P/E 2016 |
-2.96x | P/E 2017 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 4.58M 4.09M 3.78M 3.43M 6.41M 435M 6.52M 45.52M 18.02M 228M 17.21M 16.84M 719M | EV / Sales 2016 |
200x | EV / Sales 2017 | 9.19x |
| Free-Float |
88.73% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | +0.46% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.46% | +1,231.29% | - | - | 567K | |
| -2.54% | +1.75% | +56.75% | +117.82% | 1,165B | |
| -1.42% | +4.16% | +36.73% | +72.42% | 645B | |
| +0.16% | +0.79% | +24.91% | +95.34% | 504B | |
| -0.31% | +2.95% | +39.36% | +63.56% | 380B | |
| -1.34% | +0.06% | +65.81% | +41.49% | 363B | |
| -0.68% | +1.67% | +22.07% | +50.94% | 297B | |
| -1.20% | +0.99% | +2.26% | +22.95% | 269B | |
| -1.79% | +1.20% | +48.41% | +57.55% | 237B | |
| -0.73% | -0.85% | +28.47% | +100.57% | 195B | |
| Average | -0.81% | +2.68% | +36.09% | +69.18% | 450.61B | |
| Weighted average by Cap. | -1.15% | +3.25% | +40.78% | +80.33% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 945K 844K 780K 707K 1.32M 89.75M 1.34M 9.39M 3.72M 47.02M 3.55M 3.47M 148M | 1.9M 1.7M 1.57M 1.42M 2.66M 180M 2.7M 18.86M 7.47M 94.47M 7.13M 6.98M 298M |
| Net income | -53.03M -47.35M -43.75M -39.64M -74.17M -5.03B -75.4M -526M -208M -2.64B -199M -195M -8.32B | -40.58M -36.24M -33.47M -30.34M -56.75M -3.85B -57.69M -403M -159M -2.02B -152M -149M -6.36B |
| Net Debt | -13.11M -11.71M -10.81M -9.8M -18.33M -1.24B -18.64M -130M -51.52M -652M -49.2M -48.15M -2.06B | 4.27M 3.81M 3.52M 3.19M 5.97M 405M 6.07M 42.36M 16.77M 212M 16.01M 15.67M 669M |
Employees
-
Sector
Pharmaceuticals
